ArticleEuropean heart journal. Case reports2026
Fulminant growth of primary pericardial synovial sarcoma despite partial resection: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary pericardial synovial sarcomas are rare and aggressive, with limited data to guide treatment. Though advancements in cardiac imaging have improved diagnostic capabilities, these tumours are often discovered after significant disease progression. We report one of few extremely aggressive cases of pericardial sarcoma that led to in-hospital mortality. Case summary: A 59-year-old woman presented with abdominal pain and dyspnoea and was found to have cardiac tamponade. Transthoracic echocardiogram and cardiac magnetic resonance imaging revealed an 11.1 cm pericardial mass, which rapidly enlarged to 17.2 cm over 3 weeks despite partial resection. Pathology confirmed poorly differentiated synovial sarcoma with SS18::SSX2 fusion. Surgical resection and radiation were deemed infeasible due to tumour size and proximity to critical structures. She received one cycle of anthracycline-ifosfamide chemotherapy but developed airway compromise and died on hospital day 34. Discussion: This case illustrates the rapid progression and poor prognosis of primary pericardial synovial sarcoma, emphasizing that early recognition with multimodality imaging and timely surgical evaluation are crucial, as unresectable disease carries poor outcomes with current systemic therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.